Reference
Kleinjan JP, et al. Tolerance-based capecitabine dose escalation after DPYD genotype-guided dosing in heterozygote DPYD variant carriers: A single-center observational study. Anti-Cancer Drugs 30: 410-415, No. 4, Apr 2019. Available from: URL: http://doi.org/10.1097/CAD.0000000000000748 - Netherlands
Rights and permissions
About this article
Cite this article
Capecitabine. Reactions Weekly 1749, 107 (2019). https://doi.org/10.1007/s40278-019-60572-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-60572-z